Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Can CureVac Recover After Its Vaccine Setback?

TheMotleyFool

0 0

Can CureVac Recover After Its Vaccine Setback?

Many investors thought CureVac (NASDAQ: CVAC) would be the next to market with an mRNA vaccine. And soon. But the vaccine candidate's future looks uncertain after a recent trial report. In this Motley Fool Live video recorded on June 22, healthcare and cannabis bureau editor and analyst Olivia Zitkus and Fool.com contributor Adria Cimino discuss CureVac's phase 3 data report -- and what it means for the company's future in the coronavirus vaccine space.

Source Fool.com

Like: 0

CVAC

Share